Speech-Language Pathologists in Haddam, CT Accepting Medicare

2 Speech-Language Pathologists found. Showing 1 - 2

River Valley Speech Therapy, Llc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 139 Walkley Hill Rd, Haddam, CT 06438 Phone: 860-608-6242

Mrs. Morgan Renee Dalton, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 139 Walkley Hill Rd, Haddam, CT 06438 Phone: 860-608-6242

News Archive

Drugs designed to target nervous system could control inflammation in the gut, study shows

There's a reason it's called a gut feeling. The brain and the gut are connected by intricate neural networks that signal hunger and satiety, love and fear, even safety and danger. These networks employ myriad chemical signals that include dopamine, a powerful neurotransmitter most famous for its role in reward and addiction.

Mild pulses of electrical energy just as effective as more powerful and painful shocks to interrupt life-threatening rapid heartbeats

Ventricular tachycardia (VT) is a fast heartbeat originating in the heart's ventricle chamber and can be life-threatening. VT is often treated with an implantable cardioverter-defibrillator (ICD), a device that delivers an electrical shock to restore an irregular heart rhythm.

Joslin researcher identifies molecular pathway that causes neural tube defects in diabetic pregnancies

Mary R. Loeken, Ph.D., Investigator in the Section on Islet Cell and Regenerative Biology at Joslin Diabetes Center and Associate Professor of Medicine at Harvard Medical School, has discovered a molecular pathway responsible for neural tube defects in diabetic pregnancies. Her latest research findings in this pathway were published in the October issue of Diabetes.

Mapping of human genome modification during embryonic development

Scientists at The Genome Institute of Singapore (GIS) and The Scripps Research Institute (TSRI) led an international effort to build a map that shows in detail how the human genome is modified during embryonic development.

Aeolus AEOL 10150 study confirms ability to rescue skin from deleterious effects of CEES

Aeolus Pharmaceuticals, Inc. reported that researchers from National Jewish Health and the University of Colorado Anschutz Medical Campus have completed studies demonstrating that AEOL 10150 provides statistically significant protection of the skin in the 2-chloroethyl-ethylsulfide (CEES; half mustard) model of mustard gas exposure in mice and in a human cell culture model.

Read more Medical News

› Verified 7 days ago